
Sign up to save your podcasts
Or


Through conversations with leading innovators and executives across the industry, TD Cowen's ToolTalks podcast series seeks to explore the key technologies and business strategies that are transforming life science and clinical diagnostics markets today. Each episode aims to highlight the potential for Tools to enable more efficacious drugs, lower care costs, and provide better and earlier diagnoses that ultimately extend and save human lives. In the podcast's inaugural episode, TD Cowen's health care analyst Dan Brennan hosts Christian Henry, Pacific Biosciences President and CEO, to understand the progress and continued promise of next-generation sequencing to deliver new biological insights, accelerate discoveries, and power the next generation of clinical assays. We discuss Henry's experience and success with short-read NGS leader Illumina, his move to long-read sequencing leader Pacific Biosciences, and reflect on PacBio's recent success dramatically scaling/improving their technology as well as the tremendous opportunity that lies ahead across clinical, research, and applied markets. Recorded on 06/24/25
https://go.td.com/PodcastDisclosure
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
By TD Securities, TD Cowen4.8
3636 ratings
Through conversations with leading innovators and executives across the industry, TD Cowen's ToolTalks podcast series seeks to explore the key technologies and business strategies that are transforming life science and clinical diagnostics markets today. Each episode aims to highlight the potential for Tools to enable more efficacious drugs, lower care costs, and provide better and earlier diagnoses that ultimately extend and save human lives. In the podcast's inaugural episode, TD Cowen's health care analyst Dan Brennan hosts Christian Henry, Pacific Biosciences President and CEO, to understand the progress and continued promise of next-generation sequencing to deliver new biological insights, accelerate discoveries, and power the next generation of clinical assays. We discuss Henry's experience and success with short-read NGS leader Illumina, his move to long-read sequencing leader Pacific Biosciences, and reflect on PacBio's recent success dramatically scaling/improving their technology as well as the tremendous opportunity that lies ahead across clinical, research, and applied markets. Recorded on 06/24/25
https://go.td.com/PodcastDisclosure
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

3,067 Listeners

4,630 Listeners

1,940 Listeners

9,556 Listeners

941 Listeners

125 Listeners

320 Listeners

1,039 Listeners

291 Listeners

1,298 Listeners

9,932 Listeners

34 Listeners

501 Listeners

1,430 Listeners

48 Listeners